Imaging Endpoints is involved in cutting-edge COVID-19 imaging and offers the detection and standardized recording of the clinical and radiological disease features of COVID-19 infection, Radiomic Analysis, CD8+ Analysis and AI Analysis of SARS-CoV-2 for clinical trials. For more information,… Read More
Did you miss the inaugural On Point webinar discussing how the use of radiology and advanced technologies can be used to measure response for COVID-19 treatments and vaccines and lead to better decisions? Visit https://imagingendpoints.com/on-point/ for an on-demand version of… Read More
Join Imaging Endpoints’ Ronald Korn, MD, PhD, a world-renowned expert in radiology, for “On Point,” Imaging Endpoints’ new webinar series on June 23. We will be discussing how the use of radiology and advanced technologies can be used to measure… Read More
Join us for “ON POINT,” Imaging Endpoints’ new webinar series June 23. Starting with a discussion of the evolving landscape and new technologies for CT imaging of COVID-19, On Point will cover a variety of critical and timely imaging and… Read More
We have rolled out a new QMS software solution that is now used companywide – MasterControl turns our culture of quality into an operational reality. We have an improved cloud-based electronic document management system that connects application, documentation, and data… Read More
Imaging Endpoints is a team of diverse and driven professionals with a goal to change the world by Connecting Imaging to the Cure. We embrace our differences and cherish all of our brothers and sisters in humanity. That is who… Read More
Forma Therapeutics, Inc, a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced recently that the company’s investigational IDH1m inhibitor, olutasidenib, demonstrated a preliminary disease control rate of 50% in heavily pre-treated patients with predominantly enhancing, recurrent mIDH1… Read More
Scottsdale, Arizona, May 27, 2020 – Imaging Endpoints announced today that it has supported two additional U.S. Food and Drug Administration (FDA) approvals this month for new, life-saving therapies. The two New Drug Application (NDA) approvals, for two of the… Read More
Whether it is tumor blood flow, tumor microenvironment, or radiomics, Imaging Endpoints is at the leading edge of imaging science and is redefining the role an imaging core lab can provide in product development. It is one more way that… Read More
Radiomics is a rapidly growing field of radiology that extracts high-dimensional data from standard of care CT images to define a novel set of quantifiable imaging patterns – an imaging biomarker. Imaging Endpoints is a pioneer and global leader in… Read More
Featured Webinar:
Radiologic Analysis of COVID-19 Infection
June 23, 2020
